Selected article for: "cell carcinoma and transitional cell carcinoma"

Title: RESEARCH COMMUNICATIONS OF THE 28th ECVIM-CA CONGRESS
  • Document date: 2018_12_19
  • ID: r79h9yzz_1208
    Snippet: Canine transitional cell carcinoma (cTCC) cells were incubated with various concentrations of methadone and doxorubicin each, in order to test clinically achievable dose levels. Inhibition of cell proliferation was measured over 72 hours with CCK‐8 cell proliferation assay for each drug alone and different combinations. Opioid receptor density was assessed in flow cytometry in drug native and doxorubicin pre‐treated cells......
    Document: Canine transitional cell carcinoma (cTCC) cells were incubated with various concentrations of methadone and doxorubicin each, in order to test clinically achievable dose levels. Inhibition of cell proliferation was measured over 72 hours with CCK‐8 cell proliferation assay for each drug alone and different combinations. Opioid receptor density was assessed in flow cytometry in drug native and doxorubicin pre‐treated cells.

    Search related documents:
    Co phrase search for related documents
    • Canine transitional cell carcinoma and cell proliferation: 1
    • Canine transitional cell carcinoma and doxorubicin methadone: 1
    • Canine transitional cell carcinoma and transitional cell carcinoma: 1, 2, 3, 4, 5
    • cell carcinoma and doxorubicin methadone: 1
    • cell carcinoma and flow cytometry: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • cell carcinoma and receptor density: 1
    • cell carcinoma and transitional cell carcinoma: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28
    • cell proliferation and dose level: 1, 2, 3
    • cell proliferation and drug native: 1
    • cell proliferation and flow cytometry: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
    • cell proliferation and receptor density: 1, 2, 3
    • cell proliferation and transitional cell carcinoma: 1
    • cell proliferation assay and flow cytometry: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • cell proliferation assay and receptor density: 1
    • cell proliferation inhibition and flow cytometry: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • cTCC cell and doxorubicin methadone: 1
    • cTCC cell and receptor density: 1
    • different combination and dose level: 1